Home
Medicines
Companies
COVID-19
Active Ingredients
Advanced Search
Adverse Event Reporting
Login
Search Medicine Database
Home
Medicines
Companies
COVID-19
More
expand_more
Login
menu
Home
Active Ingredients
Daratumumab
Daratumumab
Medicine
Status
PIL
SPC
XPIL
EDM - Patient
EDM - HCP
Legal Category
Active Ingredient(s)
Company
DARZALEX 1,800 mg solution for injection
No Recent Update
PIL
24/06/21
SPC
24/06/21
No
EDM
10/07/20
EDM
10/07/20
A
Daratumumab
Janssen Sciences Ireland
DARZALEX 20 mg/mL concentrate for solution for infusion.
No Recent Update
PIL
28/06/21
SPC
24/06/21
No
EDM
10/07/20
EDM
10/07/20
A
Daratumumab
Janssen Sciences Ireland
This medicine and its document have not been updated in the last 30 days.
Date of Update on Medicines.ie
Product subject to medical prescription which may not be renewed (A)
